TCA Toxicity: Emergency Management and Antidote Strategies

Added:

TCA Toxicity
ECG & Antidote
Supportive Care

TCA Toxicity

0:00
Playing Section
  • 1

    TCA overdose presents with mixed toxidromes including anticholinergic, seizures, and hypotension.

  • 2

    Classic signs are mydriasis, dry skin, flushing, and potential life-threatening cardiac conduction issues.

Basic pharmacology of Tricyclic Antidepressants (TCAs), including their therapeutic mechanisms of action and receptor profiles.
Fundamental principles of electrocardiogram (EKG/ECG) interpretation, focusing on identifying standard wave complexes and measuring intervals (specifically QRS and QTc).
Cardiac cellular electrophysiology, particularly the role of fast sodium channels in Phase 0 of the action potential.
Basic acid-base physiology and chemical buffering systems in the human body, specifically how pH alterations affect drug ionization and protein binding.
Differential diagnosis of wide-complex tachycardias and other cardiotoxic drug ingestions (e.g., cocaine, diphenhydramine, or class Ia/Ic antiarrhythmics).
Advanced rescue therapies for refractory TCA-induced cardiotoxicity, such as Intravenous Lipid Emulsion (ILE) therapy and extracorporeal life support (ECLS/ECMO).
Clinical protocols for managing secondary complications of TCA toxicity, including refractory status epilepticus (using benzodiazepines vs. contraindicated agents) and severe hypotension.
Post-stabilization intensive care monitoring guidelines and psychiatric clearance protocols for patients recovering from intentional self-poisoning.
41.7K views582likes5:05@EMin5Original Release: 2015-12-22

Tricyclic antidepressant (TCA) toxicity presents with varied symptoms due to multiple mechanisms including anticholinergic effects (confusion, dilated pupils, flushed skin, dryness), seizures, hypotension, and sodium channel blockade causing cardiac toxicity. Key diagnostic features include EKG findings of widened QRS complex and dominant R wave in AVR >3mm, which correlate with severity (QRS >100ms indicates increased seizure risk, >160ms indicates risk of VTAC). Management involves sodium bicarbonate infusion titrated to improve blood pressure and narrow QRS, with contraindicated medications including beta blockers, calcium channel blockers, and amiodarone. Supportive care includes pressors for hypotension and benzodiazepines for seizures.